Further, CBD inhibition of fatty acid amino hydrolase (FAAH), the primary degradation enzyme for the endocannabinoid, anandamide, is implicated or proposed to reduce compulsive behavior (Casarotto et al., 2010), anxiety (Moreira et al., 2008), borderline personality disorder (Kolla et al., 2020), and autism spectrum disorder (Aran et al., 2019). This evidence concerns the gene FAAH and Anxiety.